Post-thaw ATP supplementation enhances cryoprotective effect of iodixanol in rat spermatozoa by Suhee Kim et al.
RESEARCH Open Access
Post-thaw ATP supplementation enhances
cryoprotective effect of iodixanol in rat
spermatozoa
Suhee Kim, Sarah Hooper, Cansu Agca and Yuksel Agca*
Abstract
Background: Successful cryopreservation of rat spermatozoa from various strains still remains a challenge. The
objective of this study was to determine if combinations of OptiPrep™ (iodixanol) and adenosine 5′-triphosphate
(ATP) can improve rat sperm function during the cryopreservation procedure.
Methods: Epididymal rat spermatozoa were frozen under different OptiPrep™ concentrations (0, 1, 2, 3 or 4 %) and
were diluted with media supplemented with or without 2 mM ATP after thawing. Post-thaw sperm motility, acrosomal
membrane integrity (AMI) and mitochondrial membrane potential (MMP) were then evaluated. In addition, the effect
of different OptiPrep™ concentrations on fresh and cooled rat spermatozoa was tested via motility.
Results: There was no effect of OptiPrep™ on motility of fresh and cooled spermatozoa. The supplementation of 1 and
2 % OptiPrep™ increased motility of frozen spermatozoa at 10 min after thawing, while it did not improve motility of
spermatozoa at 3 h after thawing in the absence of ATP. During incubation of thawed spermatozoa, the ATP addition
protected time-dependent decrease in motility after thawing in OptiPrep™-treated samples. OptiPrep™ had no effect
on AMI and MMP in frozen-thawed spermatozoa but combinations of OptiPrep™ and ATP improved MMP in frozen-
thawed spermatozoa.
Conclusions: Iodixanol has cryoprotective effects during rat sperm freezing without any toxic effect. Moreover, the
combinations of iodixanol and ATP have a beneficial role in maintaining function of frozen-thawed rat spermatozoa for
long period of incubation post-thaw.
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Background
The rat has been recognized as one of the most valuable
laboratory animals for biomedical and genomic research
[1–4]. With the production of a large number of mutant
or transgenic rat strains, there is an increasing demand
for preservation and distribution of rat lines. Although
rats are relatively easy to house and breed, it is expensive to
maintain and transport genetically modified strains [5, 6].
For this reason, cryopreservation of gametes and em-
bryos has been developed to maintain genetically
valuable materials for an extended period and facili-
tate transportation of genetic materials at a low cost
[7, 8]. In particular, cryopreservation of spermatozoa
has been well known as the most efficient way to
preserve animal germplasm [9, 10], because of simpli-
city of epididymal sperm collection, convenience of
cryopreservation method and economics for use of a
few animals [11, 12]. However, intrauterine insemin-
ation (IUI) or in vitro fertilization (IVF) using cryo-
preserved rat spermatozoa are very limited by the low
success of embryo developmental competence and
pregnancy rate in most rat strains [10, 12]. Therefore,
development of optimal protocols for rat sperm cryo-
preservation are currently ongoing [12–16].
Iodixanol was originally developed as an x-ray contrast
agent [17]. Today, it is also widely applied as a medium
for density-gradient centrifugation and cushioned centri-
fugation technique due to its inert, nontoxic, nonionic
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nol to the freezing extender helped maintain membrane
integrity and functionality during the cryopreservation
process of bovine spermatozoa [23]. It was demonstrated
that addition of minor amounts of iodixanol affected the
glass transition temperature of the solution and altered
the structure of the growing ice crystals. Currently, the
use of iodixanol for rat sperm cryopreservation has not
been reported. Here, we hypothesized that low level of
iodixanol might have cryoprotective properties without
exerting toxic effects during rat sperm cryopreservation.
Frozen-thawed viable spermatozoa often cannot main-
tain viability as long as fresh viable spermatozoa. Thus,
the energy production and supplementation are import-
ant to support motility of frozen-thawed spermatozoa
for successful cryopreservation [14, 24]. Spermatozoa
may attain access to eggs by mobilizing metabolic energy
production in the form of adenosine triphosphate (ATP)
to drive motility [25]. The freezing extender containing
exogenous ATP improved the cryosurival of rat epididy-
mal spermatozoa [14]. As modification of the above re-
ports, we thought that ATP can extend lifespan of
frozen spermatozoa post-thaw by supplying energy to
thawed spermatozoa when frozen spermatozoa are incu-
bated with thawing media containing ATP. Therefore,
the aim of this study was to evaluate protective effect of
iodixanol on rat spermatozoa during cryopreservation
and to determine maintainable effect of ATP on function
of frozen rat spermatozoa during incubation after thaw-
ing. The goal of this study was to develop an optimized
cryopreservation condition for rat spermatozoa using
iodixanol and ATP by offering proper condition for




Six sexually mature (12–15 weeks old) male rats (out-
bred Sprague-Dawley [SD] strain) were used as sperm
donors. Rats were housed in conventional rat cages at
20–25 °C in a controlled light environment (10 h dark/
14 h light) and provided free access to water and stand-
ard rodent chow. The rats were housed in accordance
with the policies of the University of Missouri Animal
Care and Use Committee and the Guide for the Care
and Use of Laboratory Animals.
Experimental design
The effect of iodixanol (OptiPrep™; 60 % w/v iodixanol
in water) was evaluated during cryopreservation of rat
spermatozoa. The OptiPrep™ concentrations for this
study were 0 % [control], 1, 2, 3 and 4 %. Epididymal
spermatozoa was divided into three as following: 1) fresh
spermatozoa were incubated with different concentrationsof OptiPrep™ for 1 h to test potential toxic effect of iodixa-
nol, 2) spermatozoa were cooled in freezing media con-
taining different concentrations of OptiPrep™ for 1 h and
3 h to determine iodixanol effect on cooling time, 3)
spermatozoa were cooled and frozen in freezing media
containing different concentrations of OptiPrep™ to evalu-
ate iodixanol effect for cryopreservation.
To check the effect of ATP after thawing, frozen sperm-
atozoa was incubated in media containing 0 mM or 2 mM
ATP after thawing. Incubation time was 10 min and 3 h to
evaluate the maintaining effect of ATP on sperm function
for long incubation. Spermatozoa frozen with different con-
centrations of OptiPrep™ were thawed and incubated with
ATP to evaluate synergistic effect of OptiPrep™ and ATP.
Sperm collection, freezing and thawing
All chemicals were purchased from Sigma Chemical (St.
Louis, MO, USA) unless otherwise stated. Male rats were
euthanized by CO2 inhalation. The cauda epididymides
were excised and placed in 35-mm petri dishes containing
HEPES-buffered Tyrode lactate (TL-HEPES) media [26]
supplemented with 3 mg/mL bovine serum albumin (BSA)
and 0.11 mg/mL pyruvic acid. The cauda epididymides
were dissected with a fine scissors to allow spermatozoa to
swim out for 10 min at 37 °C. The sperm suspension (fresh
spermatozoa) was gently drawn into a plastic Samco trans-
fer pipette (San Fernando, CA, USA) with 2-mm inner
diameter and placed in 1.5-mL Eppendorf tube. The initial
sperm concentrations were approximately 50 × 106 sperm-
atozoa/mL and only semen with ≥70 % motility was used
for this study. The collected spermatozoa were processed
individually.
The freezing extender used in this study was the TEST
(TES-Tris buffer)-sucrose-egg yolk freezing extender
comprised of 25.14 g/L N-tris (hydroxymethyl) methyl-
2-aminoethanesulfonicd acid (TES), 13.14 g/L Tris base,
27.34 g/L sucrose, 20 % (vol/vol) egg yolk and 0.75 %
(vol/vol) Equex-Paste (Minitüb, Tiefenbach, Germany).
The spermatozoa were frozen as previously described
[27]. Briefly, one part of fresh spermatozoa was mixed
with four parts of freezing extender. The diluted sperm-
atozoa were cooled at 4 °C for 60 min and were loaded
into 0.25-mL straws. The straws were placed in liquid
nitrogen (LN2) vapor for 10 min, plunged into LN2 and
stored at LN2 for at least 7 days. The straws were thawed
by holding them in water (37 °C) for 10 s. The 200 μL of
thawed spermatozoa were then diluted with 800 μL of
HEPES–buffered fertilization media (modified Kreb’s
Ringer bicarbonate [mKRB]) at the ratio of 1:4 and incu-
bated at 37 °C for evaluation.
Iodixanol treatment
Fresh spermatozoa were evaluated for motility after 1 h
incubation at 37 °C in TL-HEPES media containing
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were kept at 4 °C after addition of freezing extender con-
taining different OptiPrep™ concentration at the ratio of
1:4. The cooled samples were diluted with TL-HEPES
(1:4 ratio) 1 and 3 h after cooling initiation, incubated at
37 °C for 10 min, and evaluated for motility. Meanwhile,
spermatozoa cooled for 1 h were frozen, diluted with
fertilization media (1:4 ratio) after thawing, and incu-
bated for 10 min and 3 h at 37 °C for evaluation of mo-
tility. Thawed spermatozoa were also evaluated for
acrosomal membrane integrity (AMI) and mitochondrial
membrane potential (MMP) at 10 min after thawing.ATP treatment
To determine if ATP can play a role as an energy source
after thawing, frozen-thawed rat spermatozoa were di-
luted with fertilization media (1:4 ratio) containing ATP
(0 or 2 mM). The samples were processed as described
in above section (iodixanol treatment).Evaluation of sperm function
Sperm motility
Twenty μL of sperm suspension were loaded into 80-μm
deep dual-sided chamber (2× CELL; Hamilton Thorne
Biosciences) at 37 °C and covered with cover glass.
Computer-assisted sperm analysis (CASA, Hamilton
Thorne Biosciences Inc, Beverly, MA, USA) system was
then used to analyze the motility of rat spermatozoa
placed onto the chamber [28]. Total and progressive
motilities and average path velocity (VAP) were evalu-
ated in six fields using CASA. The setting parameters
and the definition of measured sperm motion parame-
ters for the CASA were: frames per second, 20; duration
of tracking time, 0.7 s; medium VAP cutoff, 25.0 μm/s;
low VAP cutoff, 5.0 μm/s; count slow as motile, yes.Sperm acrosomal membrane integrity
A PNA-Alexa Fluor 488/propidium iodide (PI) stain
(L21409 and L7011, Molecular Probes Inc., Eugene, OR,
USA, respectively) was used to determine AMI of rat
spermatozoa. Aliquots of 200 μL of diluted frozen
spermatozoa (2 ~ 4 × 106/mL spermatozoa) were mixed
with 1 μL of 0.2 mg/mL PNA-Alexa Fluor 488 (final
concentration, 1 μg/mL) and 1 μL of 200 μM PI (final
concentration, 1 μM). The mixture was incubated at 37 °C
for 15 min in 5 % CO2 and then was analyzed by flow
cytometry. Spermatozoa with PNA−/PI−, PNA+/PI−
and PNA+ combined PNA+/PI− and PNA+/PI+ were
considered to have viable spermatozoa with intact
acrosomal membrane, viable spermatozoa with reacted
acrosomal membrane and total spermatozoa with reacted/
or damaged acrosomal membrane, respectively.Sperm mitochondrial membrane potential (MMP)
The sperm MMP was evaluated using the JC-1 fluores-
cent dye (Molecular Probes Inc.) as previously described
[27]. Aliquots of 200 μL of diluted frozen spermatozoa
(2 ~ 4 × 106 spermatozoa/mL) were mixed with 1 μL of
100 μM JC-1 (final concentration, 0.5 μM) and 1 μL of
200 μM PI (final concentration, 2 μM) to exclude dead
spermatozoa. The mixture was incubated at 37 °C for
30 min in 5 % CO2 and then was analyzed by flow cy-
tometry. The percentage of spermatozoa with viable and
high MMP (Jagg+/PI−) and the Mean Jagg fluorescence
intensity (Jagg MFI) per viable sperm were evaluated. To
investigate the population of spermatozoa with high
MMP of viable spermatozoa, the ratio of Jagg + to viable
spermatozoa (%) was calculated as follows: (Jagg+/PI− [%] ÷
PI− [%]) × 100.
Flow cytometric analysis
All flow cytometry analyses were performed using a
FACSCalibur flow cytometer (Becton Dickinson, San
José, CA, USA) equipped with a 15 mW air-cooled
488 nm argon-ion laser and Cell Quest Pro software
(Becton Dickinson). A total of 10,000 individual sperm-
sized events were selected based on forward and side
scatter and were collected at a flow rate of < 400 events/
s. FL1 (PNA-Alexa Fluor 488), FL2 (Jagg) and FL3 (PI)
signals were detected through 530 nm, 585 nm and >
670 nm band pass filter, respectively.
Statistical analysis
Statistical analysis was performed using SPSS software
(version 17.0 for Windows; SPSS Inc., Chicago, IL). The
Shapiro-Wilk test was utilized for normality analysis of
the parameters. To compare the effect following Opti-
Prep™ concentrations, one-way repeated-measures (RM)
analysis of variance (ANOVA) was used in data with a
normal distribution and Bonferroni adjustment for mul-
tiple comparisons was used for post hoc analysis. Other-
wise, the non-parametric Friedman test and post-hoc
analysis with Wilcoxon signed ranks test was conducted
with Bonferroni correction for data that was not nor-
mally distributed. For comparisons following incubation
time and ATP supplementation, paired t-test or Wilcoxon
signed ranks test was performed according to normality
analysis. Statistical significance was set at P < 0.05 and all
tests were two-tailed. Values were presented as the mean ±
standard error of the mean (SEM).
Results
The effect of iodixanol on fresh and cooled spermatozoa
When fresh spermatozoa were exposed to TL-HEPES
with different concentrations of OptiPrep™, total motil-
ity, progressive motility and VAP were not different
among samples (P > 0.05; Fig. 1). The motility of cooled
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in different OptiPrep™ concentration (Fig. 2). There were
no significant differences in motility of cooled spermatozoa
among the different OptiPrep™ concentrations (P > 0.05).
OptiPrep™ supplementation did not prevent total and pro-
gressive motility from decreasing according to cooling time
(Fig. 2a). Total motility decreased at 3 h cooling as com-
pared to 1 h cooling and progressive motility also decreased
at 3 h cooling relative to 1 h cooling (P < 0.05) except for
2 % OptiPrep™ concentration. Duration of cooling had no
significant effect on VAP (Fig. 2b). In conclusion, supple-
mentation of OptiPrep™ did not protect decrease in sperm
motility caused by longer periods of cooling except for pro-
gressive motility shown in 2 % OptiPrep™ concentration.
These data suggest that iodixanol had no protective effect
for cooling process and no adverse effects on motility of
fresh and cooled rat spermatozoa as well.
The effect of iodixanol and ATP on motility of frozen-thawed
spermatozoa
Samples frozen with different OptiPrep™ concentrations
were evaluated for motility after thawing and incubating
in the presence or absence of ATP (Fig. 3). When the
samples were incubated for 10 min in the absence of
ATP post-thaw, the 1 and 2 % OptiPrep™ concentrations
were superior to the other groups in total sperm motility
(P < 0.05; Fig. 3a). However, there was no difference in
total motility among OptiPrep™ concentrations at 3 h in-
cubation under ATP-free media. Total sperm motility of
0, 1, 2 and 4 % OptiPrep™ showed remarkable reduction
for 3 h incubation as compared to 10 min incubation,
while only the 3 % OptiPrep™ appeared to prevent re-
duction in total motility for long incubation time post-
thaw in the absence of ATP (Fig. 3a).
Interestingly, total motility was maintained for 3 h in-
cubation in presence of ATP, without any differences be-
tween 10 min and 3 h incubation in all OptiPrep™
concentrations (Fig. 3a). In particular, total motility of
OptiPrep™-treated groups increased in ATP-supplementeda
Total Progressive
Fig. 1 The effect of OptiPrep™ on fresh rat sperm motility. The effect of Op
progressive motility (a) and VAP (b) after 1 h incubation with different conmedia as compared to ATP-free media at 3 h incubation
(Fig. 3a). The incubation with ATP-supplemented media
after thawing prevented decrease in rat sperm motility
caused by longer incubation after freezing-thawing. The
1 % OptiPrep™ concentration showed a high percentage of
total motility among different OptiPrep™ concentrations
for 3 h incubation with ATP supplementation, indicating
that combinations of iodixanol and ATP can be beneficial
system to increase and maintain the number of motile rat
spermatozoa even in longer incubation post-thaw.
There were no differences in progressive motility and
VAP among OptiPrep™ concentrations at 10 min and
3 h incubation post-thaw (Fig. 3b and c). ATP improved
VAP of 1 and 2 % OptiPrep™ concentrations at 10 min
incubation post-thaw (Fig. 3c), supporting synergistic ef-
fect of iodixanol and ATP. Three h incubation decreased
progressive sperm motility in control and 1 % OptiPrep™
and VAP in 1 % OptiPrep™ as compared to 10 min incu-
bation post-thaw in absence of ATP, while it did not
show a decrease in progressive sperm motility and VAP
in all groups in the presence of ATP. In conclusion, low
concentrations (1 and 2 %) of OptiPrep™ enhanced
sperm motility with ATP-supplementation.
The effect of iodixanol and ATP on AMI of frozen-thawed
spermatozoa
Sperm acrosomal status after freezing-thawing was
divided into 4 categories depending on PNA/PI staining
patterns using flow cytometry and epifluorescence
microscope (Fig. 4a). There was no significant difference
in the percentages of PNA−/PI− (viable and intact acro-
some), PNA+/PI− (viable and reacted acrosome) and
PNA+ (total reacted/or damaged acrosome) spermato-
zoa among samples frozen under different OptiPrep™
concentrations regardless of ATP presence (Fig. 4b–d).
However, when the frozen-thawed samples were diluted
with ATP-supplemented media, the percentage of
PNA−/PI− spermatozoa increased in control, 1 and
2 % OptiPrep™ as compared to dilution with ATP-freeCTL1 2 3 4 Optiprep (%)
b
tiPrep™ on fresh rat sperm motility was evaluated using total and
centrations of OptiPrep™ of fresh spermatozoa at 37 °C. n = 6
ba
Cooling
time1 h 3 h
*
* * * *
* * * *




Fig. 2 The effect of OptiPrep™ on cooled rat sperm motility. The effect of OptiPrep™ on cooled rat sperm motility was evaluated using
total and progressive motility (a) and VAP (b) 1 and 3 h after initiation of cooling to 4 °C with different concentrations of OptiPrep™ of
rat spermatozoa. *P < 0.05 v.s. 1 h after cooling within same iodixanol treatment groups. n = 6
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spermatozoa did not show differences in all groups by
ATP treatment (Fig. 4c) and the percentage of PNA+
spermatozoa decreased in control, 1, 2 and 3 % OptiPrep™
by dilution with ATP-supplemented media as compared
to dilution with ATP-free media (Fig. 4d). The OptiPrep™
had no effect on acrosome membrane while ATP can
maintain stability of acrosome membrane in frozen-
thawed rat spermatozoa.
The effect of iodixanol and ATP on MMP of frozen-thawed
spermatozoa
Similar to effect on acrosome membrane of OptiPrep™
and ATP, there was no significant difference in MMP
among samples frozen with different OptiPrep™ concen-
trations regardless of ATP (Fig. 4). However, ATP sup-
plementation after thawing increased the percentage of
Jagg+/PI− (viable and high MMP) spermatozoa and im-
proved MMP of viable spermatozoa in groups treated
with OptiPrep™ (Fig. 4e and f). Mean 75 % of viable fro-
zen spermatozoa were Jagg + spermatozoa without sig-
nificant differences following OptiPrep™ and ATP
treatment (Fig. 4g). The combination of OptiPrep™ and
ATP remarkably improved MMP function of frozen-
thawed rat spermatozoa.
Discussion
Recently, it has been demonstrated that iodixanol is bene-
ficial when added to a freezing extender for maintaining
membrane integrity and functionality during the cryo-
preservation process of bovine and ram semen [23, 29].
Additionally, iodixanol contributed to preserving sperm
motility after the freeze-thaw cycle. This study aimed to
determine if iodixanol exhibited similar protective effects
on rat spermatozoa during cryopreservation.
Supplementation of 5 % OptiPrep™ protected post-
thaw progressive motility, membrane integrity, acrosomalintegrity and morphological damages in ram semen [29]
and 2.5 % OptiPrep™ was superior for post-thaw motility
in bovine spermatozoa [23]. In our study, low concentra-
tions (1 or 2 %) of OptiPrep™ were superior to the higher
concentration groups 10 min after thawing under ATP-
free condition for total motility. The possible mechanisms
that iodixanol protects spermatozoa during cryopreserva-
tion are attributed to an elevation of glass transition
temperature and alteration of ice crystal formation in a
non-colligative fashion, resulting in optimal environment
for freezing [23]. Iodixanol alters ice crystal formation into
intricate nets of dendrites in a concentrations-dependent
manner during freezing [23]. Loose net of dendrites
formed by lower concentrations of OptiPrep™ helped in-
crease the cryoprotective effect on rat spermatozoa as
compared to more compact net of dendrites formed by
higher concentrations used in bovine and ram spermato-
zoa cryopreservation. Spermatozoa vary in size and shape
according to species, which may be critical factors suscep-
tible to structural changes of freezing condition by iodixa-
nol. Falciform-shaped head and long tail of rat
spermatozoa may serve as one of factors responsible for a
better protective effect in lower concentrations of Opti-
Prep™ as compared to another species.
OptiPrep™ had a cryoprotective effect on freezing, not
cooling, as shown in improved motility of 1 and 2 %
OptiPrep™ at 10 min after thawing in our study. Opti-
Prep™ did not help preventing the decrease in total
motility for longer storage of post-thaw as seen in 3 h
incubation after thawing. Inevitable decrease in motility
following time still occurred in cryopreserved rat sperm-
atozoa in spite of OptiPrep™ treatment, with highly sus-
ceptible characteristics of rat spermatozoa to various
external environments. In fact, when incubating for 3 h
after thawing, sharp declines of total motility were
observed even in 1 and 2 % OptiPrep™ groups, which



















Incubation time after thawing
Fig. 3 The effect of OptiPrep™ and ATP treatment on post-thaw
motility of rat spermatozoa. a Total motile sperm, b Progressive
motile sperm, c Average path velocity (VAP), *P< 0.05 v.s. control (CTL)
within same incubation time and ATP treatment groups (comparison
among OptiPrep™ concentrations), #P< 0.05 v.s. ATP-free within same
incubation time and OptiPrep™ groups (comparison between ATP-free
and ATP-supplemented groups), and §P< 0.05 v.s. 10 min within same
OptiPrep™ and ATP treatment groups (comparison between 10 min and
3 h incubation time). n= 6
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Based on these results, long manipulation times
consumed for AMI and MMP measurement may make
difficult to determine the effect of OptiPrep™ on cryo-
preserved rat spermatozoa.
To overcome decreases in rat sperm motility caused
by elapsed time after thawing, our second goal was to
sustain motility of frozen-thawed rat spermatozoa by
continuous supply of ATP. Both intracellular and extra-
cellular ATP molecules play key roles in sperm function
[30]. Intracellular ATP is the main energy source drivingsperm motility [30]. Extracellular ATP produces several
downstream effects that improve sperm motility by in-
creasing calcium levels or by activating cAMP signal
transduction pathways [14]. However, there were no re-
ports describing the effect of ATP on spermatozoa in
thawing media as far as we know. This is first study to
determine if supplement of ATP into thawing media can
maintain the function of rat spermatozoa survived from
cryodamage.
In this study, ATP supplementation to thawing medium
prevented the decrease in total motility observed in
groups incubated with ATP-free thawing medium for 3 h
(Fig. 3a). ATP supplemented-Optiprep™ groups showed
improvement in total motility compared to ATP-free-
Optiprep™ groups at 3 h incubation of thawing (Fig. 3a).
In particular, total motility of the 1 % Optiprep™-treated
group was superior to that of all other groups at 3 h incu-
bation after thawing in ATP-containing media. This find-
ing indicates that exogenous ATP can maintain sperm
motility for longer periods of storage after thawing and
combination of ATP and iodixanol can have a synergistic
effect on enhancement of sperm motility. Therefore, ATP
treatment with iodixanol may be beneficial during assisted
fertilization by maintaining and extending activity of func-
tional spermatozoa after freezing-thawing. In fact, extra-
cellular ATP treatment of fresh mouse spermatozoa
enhanced IVF success throughout alteration of motility by
increased intracellular calcium level [30].
ATP supplementation also led to improvement in MMP
in all groups treated with Optiprep™ as compared to ATP-
free condition. Moreover, the combination of ATP and
Optiprep™ had a strong synergistically effect in enhancing
MMP function of frozen rat spermatozoa after thawing.
However, considering that ATP increased AMI of frozen
rat spermatozoa even in Optiprep™-free group as well as 1
and 2 % Optiprep™ groups, ATP seems to improve AMI of
frozen rat spermatozoa alone regardless of Optiprep™
treatment.
The effect of extracellular ATP treatment on sperm acro-
some is controversial. Extracellular ATP was reported to in-
crease acrosomal exocytosis (AE) in human and bovine
fresh spermatozoa [31, 32] and did not affect AE in mouse
fresh spermatozoa [30], while it increased the proportion of
intact acrosomes during freezing as well as rat fresh sperm
[14]. In the current study, ATP supplementation inhibited
AE and increased acrosomal membrane integrity of cryo-
preserved rat spermatozoa in some Optiprep™ groups as
well as control group without Optiprep™ treatment, indicat-
ing that ATP may affect capacity of rat spermatozoa to
fertilize oocytes. The mechanisms that ATP influences on
AMI will be studied in rat spermatozoa in the future.
Surgical intra uterine insemination (IUI) using rat
sperm frozen in 2 % OptiPrep™ resulted in pregnancies













































Fig. 4 The effect of OptiPrep™ and ATP treatment on post-thaw AMI and MMP of rat spermatozoa. Frozen-thawed spermatozoa were stained
with PNA-Alexa 488/PI (a) and the percentages of PNA−/PI− (b), PNA+/PI− (c) and PNA+/PI+ (d) were analyzed with flow cytometry. Using JC-1/
PI staining, viable spermatozoa with high MMP (e), Mean Jagg fluorescence intensity (Jagg MFI) per viable sperm (f), ratio of spermatozoa with high
MMP of viable spermatozoa (g) were evaluated for MMP. PNA−/PI−: viable and acrosome-intact, PNA+/PI−: viable and acrosome-reacted, PNA+/PI
+: dead and acrosome-reacted/or damaged, PNA−/PI+: dead, PNA+: total acrosome-reacted/or damaged. *P < 0.05 v.s. ATP-free within OptiPrep™
groups (comparison between ATP-free and ATP-supplemented groups). n = 6
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4 out of 11 (36 %) rats became pregnant using frozen-thaw
sperm treated with 2 % OptiPrep™ (Additional file 1: Table
S1). Although we did not compare the pregnancy and deliv-
ery rate between the absence and presence of OptiPrep™,
this study led to a possibility for fertilization and pregnancy
using frozen-thawed rat spermatozoa. Further testing on
OptiPrep™ will be needed to overcome low fertilization and
pregnancy rate of frozen rat spermatozoa [12, 33].Conclusion
Iodixanol supplementation with low concentrations to
freezing extender increased post-thaw motility. ATP pro-
tected spermatozoa from the decrease in motility by
post-thaw time and improved AMI & MMP when com-
bined with iodixanol. This study suggests that combina-
tions of iodixanol and ATP may lead successful freezing
and fertilization of rat spermatozoa by cryoprotective
effect of iodixanol during freezing and maintenance
ability of ATP after thawing.Additional file
Additional file 1: The additional file included method and data for
“Developmental competence of frozen-thaw rat spermatozoa in the
presence of 2 % Optiprep™ after surgical intra uterine insemination.”
For more detail, see Additional file 1. (PDF 78 kb)
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